Literature DB >> 11806404

Sarcopenia and hypertrophy: a role for insulin-like growth factor-1 in aged muscle?

Mahjabeen Hameed1, Stephen D R Harridge, Geoffrey Goldspink.   

Abstract

Sarcopenia is the loss of muscle mass associated with the aging process. Although systemic or circulating growth hormone and insulin-like growth factor-1 levels fall as we age, this is likely to be of lesser importance in regard to muscle mass than the role of locally produced insulin-like growth factor-1s generated in the muscle in response to exercise.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11806404     DOI: 10.1097/00003677-200201000-00004

Source DB:  PubMed          Journal:  Exerc Sport Sci Rev        ISSN: 0091-6331            Impact factor:   6.230


  15 in total

Review 1.  Validated treatments and therapeutic perspectives regarding physical activities.

Authors:  Y Rolland; F Pillard
Journal:  J Nutr Health Aging       Date:  2009-10       Impact factor: 4.075

Review 2.  Muscle quality in aging: a multi-dimensional approach to muscle functioning with applications for treatment.

Authors:  Maren S Fragala; Anne M Kenny; George A Kuchel
Journal:  Sports Med       Date:  2015-05       Impact factor: 11.136

Review 3.  Role of protein and amino acids in the pathophysiology and treatment of sarcopenia.

Authors:  Hans C Dreyer; Elena Volpi
Journal:  J Am Coll Nutr       Date:  2005-04       Impact factor: 3.169

4.  Growth hormone stimulates the collagen synthesis in human tendon and skeletal muscle without affecting myofibrillar protein synthesis.

Authors:  Simon Doessing; Katja M Heinemeier; Lars Holm; Abigail L Mackey; Peter Schjerling; Michael Rennie; Kenneth Smith; Søren Reitelseder; Anne-Marie Kappelgaard; Michael Højby Rasmussen; Allan Flyvbjerg; Michael Kjaer
Journal:  J Physiol       Date:  2009-11-23       Impact factor: 5.182

5.  The effect of recombinant human growth hormone and resistance training on IGF-I mRNA expression in the muscles of elderly men.

Authors:  M Hameed; K H W Lange; J L Andersen; P Schjerling; M Kjaer; S D R Harridge; G Goldspink
Journal:  J Physiol       Date:  2003-10-17       Impact factor: 5.182

6.  Muscle-Bone Interactions Across age in Men.

Authors:  Ian J Palmer; Eric D Runnels; Michael G Bemben; Debra A Bemben
Journal:  J Sports Sci Med       Date:  2006-03-01       Impact factor: 2.988

Review 7.  Effects of aging on muscle fibre type and size.

Authors:  Michael R Deschenes
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

Review 8.  Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives.

Authors:  Y Rolland; S Czerwinski; G Abellan Van Kan; J E Morley; M Cesari; G Onder; J Woo; R Baumgartner; F Pillard; Y Boirie; W M C Chumlea; B Vellas
Journal:  J Nutr Health Aging       Date:  2008 Aug-Sep       Impact factor: 4.075

9.  Age-related cardiac muscle sarcopenia: Combining experimental and mathematical modeling to identify mechanisms.

Authors:  Jing Lin; Elizabeth F Lopez; Yufang Jin; Holly Van Remmen; Terry Bauch; Hai-Chao Han; Merry L Lindsey
Journal:  Exp Gerontol       Date:  2007-12-15       Impact factor: 4.032

10.  Insulin/IGF-1 signaling, including class II/III PI3Ks, β-arrestin and SGK-1, is required in C. elegans to maintain pharyngeal muscle performance during starvation.

Authors:  Donard S Dwyer; Eric J Aamodt
Journal:  PLoS One       Date:  2013-05-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.